Posts tagged USA
The Colon Club (a fun and fabulous non-profit in New York state) has just released the 7th edition of its yearly Colondar, a calendar initiative that features colorectal cancer survivors showing a little skin for a great cause.
“The 2011 Colondar is another stunning take on thirteen colorectal cancer survivors all diagnosed under the stereotypical age of 50. As with every Colondar, the featured survivors proudly show off their surgical scars and share part of their extraordinary personal stories, proving that this is a disease that can happen to anyone, at any age.”
The unfortunate truth is that rates of colorectal cancer are on the rise in younger people, and that men and women are about equally likely to be diagnosed. Colorectal cancer is a leading cause of cancer death in both Canada and the United States.
THURSDAY, April 15 (HealthDay News) — Many American doctors don’t make proper use of a colorectal cancer screening method called the fecal occult blood test, a new study claims.
Researchers from the U.S. Centers for Disease Control and Prevention surveyed 1,134 primary care physicians and found that 75 percent of them order or perform an in-office fecal occult blood test (FOBT), rather than relying on the more accurate home-based FOBT.
National guidelines recommend that FOBT testing be done with stool samples collected at home. The in-office test — in which a single stool sample is collected by a physician during a digital rectal examination — is not recommended for colorectal cancer screening because it misses 95 percent of cancers or precancerous polyps. Click here to read the full article.
Arm yourself with knowledge. The Colorectal Cancer Association of Canada wants to encourage you to be an informed patient before and after a colorectal cancer diagnosis. We’re currently working on expanding our Screening Tests and Up-and-Coming Screening Tests pages in order to reflect the incredible advancements in diagnosing our nation’s second most deadly cancer. As always, the CCAC encourages you to maintain open communication with your primary care physician about all concerns you have- including concerns about the efficacy of screening procedures.
Quebec City-based drug developer Aeterna Zentaris Inc. and U.S. partner Keryx Biopharmaceuticals confirmed that U.S. regulators have granted fast-track approval for perifosine (KRX-0401), an oral treatment for colorectal cancer. The full US approval and market launch wouldn’t be until 2012, with the next two years spent in Phase III clinical trials. Perifosine already has “orphan drug” status in Europe and the USA for the treatment of blood cancer.
The CCAC blog may not be the place for politics- but it is the place for breaking news regarding the access to colorectal cancer screening and treatment in Canada and abroad.
As Canadians, we tend to be very interested in the American health care reform- after all, our system is the one that the US system is compared to the most. For better or worse, access to site health care is a very hot issue. Politics and ideology aside, our American friends may be interested in what the reform means for them- and their chances of preventing, treating and beating colorectal cancer.
Below, a small preview of a Colorectal Cancer Coalition article entitled, “What Does Health Care Reform Mean For People Concerned About Colorectal Cancer? Please click here to read the original article- it’s a very important read.
BENEFITS IF YOU HAVE BEEN DIAGNOSED WITH COLORECTAL CANCER:
- Beginning immediately, health insurance plans cannot drop you or reduce your benefits just because you become sick, a process called rescission.
- After January 1, 2014, insurance plans will not be able to deny coverage or charge higher premiums if you have a pre-existing condition. Until that time, people with pre-existing conditions will be able to find affordable insurance in special high-risk pools supported with federal funds. For people with inherited colorectal cancer who worry about testing for a genetic condition, the law specifically includes genetic information among the health conditions for which there cannot be discrimination.
- Six months after the the law is enacted, insurance companies can no longer place lifetime limits on healthcare coverage, nor can they impose restrictive annual limits.
- In 2014, all group and individual plans must eliminate annual limits. Even if you need expensive cancer care, you will no longer need to worry about your insurance refusing to meet those costs.
- Depending on your income, there will be limits on the amount of money you need to pay out-of-pocket for health care for you and for your family each year
“Virtual Colonoscopy” gets a whole new meaning as Mayo Clinic prepares to host a colon cancer event in Second Life. You may have heard of Second Life- a unique simulation community where users interact through the use of avatars. Turns out it can be the source of some vital information about your health! Mayo Clinic is diving headfirst into the 21st century with a 100% virtual colon cancer information session at 3:30 p.m. CDT today.
The 100% online event is being put on to recognize the close of Colorectal Cancer Awareness Month. Dr. Paul Limburg (Departments of Gastroenterology and Hepatology and Preventive, Occupational, and Aerospace Medicine) will be giving a lecture on “Tools & Tips to Prevent Colorectal Cancer.”
For more information about how to participate (or to download and join Second Life) visit this page on Mayo Clinic in Second Life.
You may have noticed that the CCAC is increasing its web presence- do you think we should conquer this virtual world, too?
Most Canadians have the benefit of screening networks at the provincial level, and we believe that all people around the world deserve that same opportunity.
To that end, our friends at the Colorectal Cancer and Colon Cancer coalitions south of the border have their own Buttmob forming, and it’s all in the name of advocacy. Tell your American friends:
Call your congressman on Tuesday March 30, 2010 and urge them to support the Colorectal Cancer Prevention, Early Detection and Treatment Act. Americans around the country will be calling their legislators as part of the “Congressional Butt-In” a day-long effort organized by C3: Colorectal Cancer Coalition. On that day, constituents are urged to flood their legislators offices with phone calls about important programs which would not only save millions of taxpayer dollars, but more importantly, have a positive impact on the number of colon cancer deaths each year.
Think about it:
“A National Colorectal Cancer Screening Program has the potential to help tens of thousands of Americans each year get the screening they need, at a fraction of what it would cost to care for their late stage cancer diagnoses if their care was delayed until they were in the Medicare system.” – C3: Colorectal Cancer Coalition
Here’s some proud Canadian advocacy news: Newfoundland and Labrador has finally announced its intention to create a population-based screening program! Newfoundland was the last remaining province without a screening network. Over 500,000 Canadians there will now have better access to lifesaving tests. Stay tuned for details on the program’s implementation.
Click here to learn more about the CCAC’s advocacy goals.
The American Cancer Society has given the state of Wisconsin a failing grade when it comes to colorectal cancer prevention. It’s one of only a few states without any laws requiring insurance providers to cover the cost of a colorectal cancer screening. Luckily, lawmakers are considering creating such a law.
“People in Wisconsin want their lawmakers to do everything they can to combat cancer in this state and there’s no reason they should continue to accept an ‘F’ grade on this matter,” said Bob Meyer, Wisconsin Government Relations Director for the American Cancer Society.
Let’s hope for change in Wisconsin!
Here in Canada, only one province has yet to commit to creating a population-based screening program- Newfoundland. Quebec is still working on its pilot program, and PEI’s launched recently. The CCAC continues to advocate for equal access to screening and treatment options for all provinces.
View the original article here.